NCRI Press Release, 9 November 2016
Marker for aggressive prostate cancer doubles-up as a drug target
Download the attachment-
RT @Mesouk : Help shape the future of #cancer #research by taking part in a survey by the Nat'l Cancer Research Institute. Open until 25 Apr…
2 months ago -
RT @ecancer : Registration and abstract submission for the 2018 @NCRI_partners Cancer Conference is now live! Sign up today to discover the…
2 months ago -
RT @drol007 : Second chance at @LindAlliance @NCRI_partners survey https://t.co/j51JVamVr7
2 months ago
What's Happening
- 18 Jun 2018We are currently looking for a new Chair for the NCRI Head & Neck Cancer CSG and a new Bladder Vice Chair for the Bladder & Renal Cancer CSG
- 18 Jun 2018We are now recruiting new members for our various Clinical Studies Groups. Application deadline: 2 July 2018
- 15 Jun 2018We are now seeking trainees for our various NCRI Clinical Studies Groups and SPED Advisory Group
- 18 May 2018NCRI Consumer Membership Applications to the CSGs - Now Open
- 18 May 2018NCRI Consumer Membership Applications to CTRad - Now Open
- 3 May 2018Dr Iain Frame appointed NCRI CEO
RSS Feed